Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines

Area of Science:

• Oncoimmunology
• Biomaterials Science
• Vaccine Development

Background:

• Current immunotherapies show limited efficacy against solid and immunologically cold tumors.
• Oncoimmunology successes highlight the potential of boosting host immunity against cancer.
• Significant patient subsets benefit from immunotherapies that eradicate tumors.

Purpose of the Study:

• To review biomaterial-based strategies for cancer vaccines in immunotherapy.
• To explore how biomaterials enhance the cancer-immunity cycle.
• To detail methods for inducing anti-tumor lymphocytic responses.

Main Methods:

• Discussing biomaterial-based vaccine formulations for cancer immunotherapy.
• Highlighting strategies for recruiting and activating dendritic cells.
• Examining the induction of T cell responses via cross-presentation.

Main Results:

• Biomaterial vaccines enhance cellular recruitment and activation against tumor antigens.
• Strategies focus on immunostimulatory gradients to attract and activate dendritic cells.
• Effective cross-presentation in lymphoid organs generates anti-tumor immunity.

Conclusions:

• Biomaterial-based cancer vaccines offer a promising approach to immunotherapy.
• These vaccines can activate and expand tumor-specific T cells.
• Personalized cancer vaccines hold potential for long-term systemic immunity and remission.